Literature DB >> 29777395

Therapeutic Approach to Hypertension Urgencies and Emergencies in the Emergency Room.

Alessandro Maloberti1,2, Giulio Cassano1, Nicolò Capsoni1, Silvia Gheda1, Gloria Magni1, Giulia Maria Azin1, Massimo Zacchino1, Adriano Rossi1, Carlo Campanella1, Andrea Luigi Roberto Beretta3, Andrea Bellone3, Cristina Giannattasio4,5.   

Abstract

Hypertensive urgencies-emergencies are important and common events. They are defined as a severe elevation in BP, higher than 180/120 mmHg, associated or not with the evidence of new or worsening organ damage for emergencies and urgencies respectively. Anamnestic information, physical examination and instrumental evaluation determine the following management that could need oral (for urgencies) or intravenous (for emergencies) anti-hypertensives drugs. The choice of the specific drugs depend on the underlying causes of the crisis, patient's demographics, cardiovascular risk and comorbidities. For emergencies a maximum BP reduction of 20-25% within the first hour and then to 160/110-100 over next 2-6 h, is considered appropriate with a further gradual decrease over the next 24-48 h to reach normal BP levels. In the case of hypertensive urgencies, a gradual lowering of BP over 24-48 h with an oral medication is the best approach and an aggressive BP lowering should be avoided. Subsequent management with particular attention on chronic BP values control is important as the right treatment of the acute phase.

Entities:  

Keywords:  Emergency department; Hypertensive emergencies; Hypertensive urgencies; Therapeutic approach

Mesh:

Substances:

Year:  2018        PMID: 29777395     DOI: 10.1007/s40292-018-0261-4

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  49 in total

1.  Effectiveness and safety of prehospital urapidil for hypertensive emergencies.

Authors:  J Alijotas-Reig; I Bove-Farre; F de Cabo-Frances; R Angles-Coll
Journal:  Am J Emerg Med       Date:  2001-03       Impact factor: 2.469

2.  Intravenous nicardipine in the treatment of postoperative arterial hypertension.

Authors:  J L Vincent; G Berlot; J C Preiser; E Engelman; J P Dereume; R J Khan
Journal:  J Cardiothorac Vasc Anesth       Date:  1997-04       Impact factor: 2.628

Review 3.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

4.  Hypertensive crisis profile. Prevalence and clinical presentation.

Authors:  José Fernando Vilela Martin; Erika Higashiama; Evandro Garcia; Murilo Rizzatti Luizon; José Paulo Cipullo
Journal:  Arq Bras Cardiol       Date:  2004-08-17       Impact factor: 2.000

5.  Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry.

Authors:  Jason N Katz; Joel M Gore; Alpesh Amin; Frederick A Anderson; Joseph F Dasta; James J Ferguson; Kurt Kleinschmidt; Stephan A Mayer; Alan S Multz; W Frank Peacock; Eric Peterson; Charles Pollack; Gene Yong Sung; Andrew Shorr; Joseph Varon; Allison Wyman; Leigh A Emery; Christopher B Granger
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

6.  Hydralazine kinetics in hypertensive patients after intravenous administration.

Authors:  T M Ludden; A M Shepherd; J L McNay; M S Lin
Journal:  Clin Pharmacol Ther       Date:  1980-12       Impact factor: 6.875

7.  Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans.

Authors:  K S Olsen; L B Svendsen; F S Larsen; O B Paulson
Journal:  Br J Anaesth       Date:  1995-07       Impact factor: 9.166

Review 8.  Treatment of acute severe hypertension: current and newer agents.

Authors:  Joseph Varon
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Prevalence, determinants, and clinical significance of cardiac troponin-I elevation in individuals admitted for a hypertensive emergency.

Authors:  Luis Afonso; Himabindu Bandaru; Ankit Rathod; Apurva Badheka; Mohammad Ali Kizilbash; Hammam Zmily; Gordon Jacobsen; Joseph Chattahi; Tamam Mohamad; Jayanth Koneru; John Flack; W Douglas Weaver
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-06-27       Impact factor: 3.738

10.  Intravenous clevidipine for management of hypertension.

Authors:  Alma Rivera; Elsa Montoya; Joseph Varon
Journal:  Integr Blood Press Control       Date:  2010-06-28
View more
  1 in total

1.  Immediate Prescription of Oral Antihypertensive Agents in Hypertensive Urgency Patients and the Risk of Revisits with Elevated Blood Pressure.

Authors:  Pungkava Sricharoen; Aroonkamol Poungnil; Chaiyaporn Yuksen
Journal:  Open Access Emerg Med       Date:  2020-11-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.